Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis

Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis

Resource Type

CF Research News

Authors

VanDevanter DR, Heltshe SL, Spahr J, Beckett VV, Daines CL, Dasenbrook EC, Gibson RL, Jain R, Sanders DB, Goss CH, Flume PA; STOP Study Group.

References

J Cyst Fibros. 2017 Apr 21. pii: S1569-1993(17)30100-5

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Clinical trial [3]
endpoints [4]
Exacerbation [5]
Sample size [6]

Date

Friday, April 21, 2017

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/rationalizing-endpoints-prospective-studies-pulmonary-exacerbation

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-16-00311R1_FINAL_VanDevanter_06052017.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=RATIONALIZING%20ENDPOINTS%20FOR%20PROSPECTIVE%20STUDIES%20OF%20PULMONARY%20EXACERBATION%20TREATMENT%20RESPONSE%20IN%20CYSTIC%20FIBROSIS%20Clinical%20trial%2C%20Endpoints%2C%20Exacerbation%2C%20Sample%20size [3] https://www.ecfs.eu/research-article-keywords/clinical-trial [4] https://www.ecfs.eu/research-article-keywords/endpoints [5] https://www.ecfs.eu/research-article-keywords/exacerbation [6] https://www.ecfs.eu/research-article-keywords/sample-size [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines